Prognosis
FDA Covid Vaccine Guidance Throws Cold Water on Trump 2020 Goal
- SVB Leerink says emergency use authorization likely early 2021
- Getting enough Americans to vaccinate another hurdle
This article is for subscribers only.
The Food and Drug Administration’s new standards on Covid-19 vaccine development may dampen Wall Street hopes that a shot to prevent the spread of the pandemic will be available before the U.S. election in November.
With the FDA’s standards for an emergency use authorization not much lower than what’s needed for full approval, the first authorization seems more likely to happen in early 2021, said Geoffrey Porges, an analyst with SVB Leerink.